FDA Can Regulate Stem Cell Treatments, DC Circ. Rules – Law360 (subscription)
|
FDA Can Regulate Stem Cell Treatments, DC Circ. Rules
Law360 (subscription) Law360, Los Angeles (February 04, 2014, 5:00 PM ET) — The D.C. Circuit on Tuesday ruled that Regenerative Sciences LLC’s stem cell treatment is a drug and therefore subject to U.S. Food and Drug Administration regulations, rejecting the company’s … |
